Overview

Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema

Status:
Terminated
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This randomized clinical trial studies an investigational drug in preventing lymphedema in patients at high risk after undergoing axillary lymph node dissection. The study drug may prevent lymphedema in patients undergoing axillary lymph node dissection.
Phase:
N/A
Details
Lead Sponsor:
Stanford University
Treatments:
Ketoprofen